Phathom Pharmaceuticals, Inc. PHAT Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s other working capital?
- Phathom Pharmaceuticals, Inc. (PHAT) reported other working capital of -$1.61M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s other working capital changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s other working capital increased by 11.3% year-over-year, from -$1.81M to -$1.61M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s other working capital?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s other working capital has grown at a 58.6% compound annual growth rate (CAGR), from -$823K to -$5.21M.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.